Researchers from the Fred Hutchinson Cancer Center in Seattle have tested a new HIV vaccine using mRNA, the technology behind many COVID-19 vaccines. Scientists say results from the early-stage clinical trial offer hope for significant progress in the global effort to develop a safe and effective HIV vaccine. For this episode of Weekend One on One, Angelica Waite has been speaking with Associate Professor Seth Cheetham, Deputy Director of BASE mRNA at the University of Queensland to learn more about the study, and what it means for HIV vaccine research
INTERVIEW: High hopes for new HIV vaccine
Share
